داروسازی کاسپین تامین
کاسپین | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 35,240 2.97
Close Price: 35,240
Income Statement
AGM
Interim
2026/07/08 Fiscal Year 2026/03/2012 Month | 2025/05/17 Fiscal Year 2025/03/2012 Month | 2024/05/15 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 48.588 Trillion | 25.333 Trillion | 16.588 Trillion | |
Total Revenues | 48.588 Trillion | 25.333 Trillion | 16.588 Trillion | |
Cost of Goods Sold | 16.506 Trillion | 11.058 Trillion | 8.85 Trillion | |
Gross Profit | 32.081 Trillion | 14.275 Trillion | 7.738 Trillion | |
General & Administrative Expenses | 884.908 Billion | 580.011 Billion | 418.886 Billion | |
Net Operating Income & Expenses | 25.735 Billion | 55.047 Billion | 65.019 Billion | |
Operating Profit (Loss) | 31.222 Trillion | 13.75 Trillion | 7.384 Trillion | |
Profit Before Tax | 27.627 Trillion | 11.28 Trillion | 5.858 Trillion | |
Tax | 5.814 Trillion | 1.497 Trillion | 1.315 Trillion | |
Net Profit (Loss) After Tax | 21.813 Trillion | 9.783 Trillion | 4.543 Trillion | |
Retained Earnings at Beginning of Period | 11.449 Trillion | 4.886 Trillion | 3.438 Trillion | |
Approved Dividends — Prior Year AGM | -7.98 Trillion | -3.22 Trillion | -3.095 Trillion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | -1.502 Trillion | - | - | |
Allocable Profit | 23.781 Trillion | 11.449 Trillion | 4.886 Trillion | |
Legal Reserve | 654 Billion | - | - | |
Approved Dividends — Current Year | 15.324 Trillion | 7.98 Trillion | 3.22 Trillion | |
Retained Earnings at End of Period | 7.803 Trillion | 3.469 Trillion | 1.666 Trillion |